Val J. Lowe, MD, ECOG-ACRIN Cancer Research Group (IMAGE)
Caption
"The findings from ACRIN 6685 suggest that FDG-PET/CT may assist the clinician in deciding on the best therapy for the clinically N0 neck in head and neck squamous cell carcinoma, possibly preventing patient morbidity and/or saving significant costs."
Credit
Mayo Clinic
Usage Restrictions
None
License
Licensed content